Salaverri Burgio & Wetzler Malbrán has assisted Crown Point Energía (CPESA) in the transaction. Crown Point Energía (CPESA) executed the issuance of its Class IV Notes...
Crown Point Energia’s $7,47 Million Notes Offering
Alexion, AstraZeneca Rare Disease in Deal with Pfizer
Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...